- Saturday, June 26, 2010, 18:04
- Anal Cancer
- 21
Prospectively collected resource utilization and health utility data for patients with CRC in the CO.17 study who received best supportive care +/- cetuximab were assessed for cost effectiveness. Journal of the National Cancer Institute (Source: Medscape Hematology-Oncology Headlines)
Go to SourceRelated Sites
Cancer Center in Pittsburgh Warns of Cell Phone Risks | GEEK!Article Study» Article Study - Free ...
Full story
- Friday, June 18, 2010, 15:38
- Anal Cancer
- 4
New research studied the association between prostate-specific antigen levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However, the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer. (Source: ScienceDaily Headlines)
Go to Source Full story
- Friday, June 11, 2010, 0:48
- Esophageal Conditions
- 280
Vitreomacular traction (VMT) syndrome is characterized as a partial detachment of the posterior vitreous with persistent adherence to the macula. The dynamic process associated with macular traction may induce a variety of macular conditions including cystoid macular edema (CME), epiretinal membranes (ERM), and macular hole formation. METHODS: Dilated fundus evaluations as well as Stratus and Cirrus optical coherence tomography (OCT) (Zeiss-Humphrey, Dublin, California) imaging were ...
Full story
- Saturday, March 20, 2010, 7:16
- Health News
- 3
GE Healthcare, the $17 billion medical technology division of General Electric Company (NYSE:GE), today announced the Mac-Lab's validation of compatibility with the Volcano's SmartMap® Pressure Instrument and PrimeWire® Pressure Guide Wire for evaluation of Fractional Flow Reserve (FFR). Coronary heart disease caused 425,425 deaths in 2006 and is the single leading cause of death in America today1. It is caused by ...
Full story
- Wednesday, February 17, 2010, 16:35
- Health News
- 2
Centocor Ortho Biotech Products, L.P. and Amgen Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include PROCRIT® (Epoetin alfa), Aranesp® (darbepoetin alfa) and EPOGEN® (Epoetin alfa)...
Go to Source Full story
- Saturday, January 23, 2010, 20:57
- Rectal Bleeding
- 10
Two studies were conducted to assess the performance of a commercially available neck-mounted activity meter to detect cows about to ovulate in two paddock-based Holstein-Friesian dairy herds. The activity monitoring system recorded cow activity count in 2-hourly periods. Study I investigated the ability of the system to detect cow ovulatory periods in dairy herds managed in two different Australian environments and breeding systems using five ...
Full story
- Friday, December 11, 2009, 15:04
- Health News
- 20
The Special Feature of the November/December 2009 issue of the Journal of the American Pharmacists Association JAPhA® is a "White paper on designing a risk evaluation and mitigation strategies (REMS) system to optimize the balance of patient access, medication safety, and impact on the health care system." The paper results from the input of an expert panel of stakeholders convened by the American ...
Full story
- Saturday, December 5, 2009, 15:57
- Health News
- 52
UroToday.com - Randomized three-dimensional conformal radiotherapy dose escalation studies have consistently shown improved biochemical control rates for prostate cancer. This benefit was associated with the problem of increased rectal toxicity. The increasing implementation of image-guided radiotherapy (IGRT) allows a reduction of safety margins around the clinical target volume (CTV). Thus, the same or improved local tumour control with lower rectal toxicity due to reduced rectal ...
Full story
- Tuesday, December 1, 2009, 17:07
- Health News
- 14
In the online edition of the British Journal of Urology, the Department of Urology at the University of Miami reported on the impact of prior pelvic radiotherapy (XRT) on the occurrence of uretero-intestinal anastomosis (UIA) stricture at subsequent urinary diversion.
Pelvic XRT can potentially affect small blood vessels and induce tissue fibrosis. In patients who have not had prior pelvic XRT, the incidence of UIA stricture ...
Full story
- Tuesday, December 1, 2009, 17:07
- Health News
- 21
Bayer Schering Pharma AG, Germany, is progressing with the development of florbetaben to support Alzheimer diagnosis. On the occasion of the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), the company announced the enrollment of first patients in an international clinical Phase III trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection ...
Full story